Jump to Content


The next generation of the VITALITI CVSM (version 3.0) is currently under design and development and is the subject of the proposed verification and validation clinical trials with PHRI. It aims to add enhancements to the current design for improved vital sign accuracy, biometric signal capture at high fidelity, and consumer-friendly usability. This product release will also be the transition point from a prototype design to a commercially viable product. Design enhancements are also to focus on meeting the standards for the approval processes for both the FDA and Health Canada as a regulated medical device, as well as best design practices to manufacture at large scale production volumes.

southlake-regional-health-centre logo
clouddx logo

Solution Type